1.
Zambrano C, Garitaonaindia MT, Salmerón D, et al. Melatonin decreases human adipose tissue insulin sensitivity. Journal of pineal research. 2024;76(5):e12965. doi:10.1111/jpi.12965.
1.
Chen Z, Ghavimi SAA, Wu M, et al. PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells. JCI insight. 2023;8(24). doi:10.1172/jci.insight.165324.
1.
Chitraju C, Fischer AW, Ambaw YA, et al. Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesity. eLife. 2023;12. doi:10.7554/eLife.88049.
1.
Inouye KE, Prentice KJ, Lee A, et al. Endothelial-derived FABP4 constitutes the majority of basal circulating hormone and regulates lipolysis-driven insulin secretion. JCI insight. 2023;8(14). doi:10.1172/jci.insight.164642.
1.
Yang J, Vamvini M, Nigro P, et al. Single-cell dissection of the obesity-exercise axis in adipose-muscle tissues implies a critical role for mesenchymal stem cells. Cell Metab. 2022;34(10):1578-1593.e6. doi:10.1016/j.cmet.2022.09.004.
1.
Zhang Y, Federation AJ, Kim S, et al. Targeting nuclear receptor NR4A1-dependent adipocyte progenitor quiescence promotes metabolic adaptation to obesity. J Clin Invest. 2018;128(11):4898-4911. doi:10.1172/JCI98353.
1.
Pulit SL, Stoneman C, Morris AP, et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum Mol Genet. 2019;28(1):166-174. doi:10.1093/hmg/ddy327.
1.
Grotenhuis N, Koopman JP, Kruyt JM, Rothuizen LT, Knevel R, Blom H. Implementation of the hyaluronic acid fat graft myringoplasty technique, pitfalls and lessons learned. Acta Otolaryngol. 2017;137(10):1035-1038. doi:10.1080/00016489.2017.1330556.
1.
Charles KN, Li M-D, Engin F, Arruda AP, Inouye K, Hotamışlıgil GS. Uncoupling of Metabolic Health from Longevity through Genetic Alteration of Adipose Tissue Lipid-Binding Proteins. Cell Rep. 2017;21(2):393-402. doi:10.1016/j.celrep.2017.09.051.
1.
Mercader JM, Liao RG, Bell AD, et al. A Loss-of-Function Splice Acceptor Variant in Is Protective for Type 2 Diabetes. Diabetes. 2017;66(11):2903-2914. doi:10.2337/db17-0187.